Skip to main content

Table 3 MFM scores at T0 and Y1 for patients older than 2 years

From: Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study

Age at treatment onset T0Y1P
 MFM total score42 / 44 (4–87)47 / 50 (6–78)< 0.001
All patients (n = 68)MFM D17 / 4 (0–83)7 / 3 (0–50)0.245
MFM D263 / 67 (1–100)71 / 76 (2–100)< 0.001
MFM D374 / 81 (10–100)81 / 88 (14–100)< 0.001
2–5 years
(n = 33)
MFM total score45 / 45 (10–87)52 / 53 (16–78)< 0.001
MFM D110 / 4 (0–83)10 / 4 (0–50)0.144
MFM D266 / 71 (1–100)77 / 83 (22–100)< 0.001
MFM D374 / 83 (24–100)84 / 92 (38–100)0.001
6–17 years (n = 35)MFM total score40 / 43 (4–60)43 / 47 (6–63)0.099
MFM D14 / 3 (0–25)3 / 3 (0–13)0.651
MFM D261 / 63 (6–96)64 / 69 (2–97)0.457
MFM D373 / 81 (10–100)79 / 86 (14–100)0.04
  1. The values shown are average / median (range). Statistically significant differences (p < 0.05) are highlighted in bold font